Cargando…

Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus

PURPOSE: In diabetes mellitus type 2, capillary rarefaction plays a pivotal role in the pathogenesis of end-organ damage. We investigated retinal capillary density in patients with early disease. METHODS: This cross-sectional study compares retinal capillary rarefaction determined by intercapillary...

Descripción completa

Detalles Bibliográficos
Autores principales: Jumar, Agnes, Harazny, Joanna M., Ott, Christian, Friedrich, Stefanie, Kistner, Iris, Striepe, Kristina, Schmieder, Roland E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147800/
https://www.ncbi.nlm.nih.gov/pubmed/27935938
http://dx.doi.org/10.1371/journal.pone.0162608
_version_ 1782473733215092736
author Jumar, Agnes
Harazny, Joanna M.
Ott, Christian
Friedrich, Stefanie
Kistner, Iris
Striepe, Kristina
Schmieder, Roland E.
author_facet Jumar, Agnes
Harazny, Joanna M.
Ott, Christian
Friedrich, Stefanie
Kistner, Iris
Striepe, Kristina
Schmieder, Roland E.
author_sort Jumar, Agnes
collection PubMed
description PURPOSE: In diabetes mellitus type 2, capillary rarefaction plays a pivotal role in the pathogenesis of end-organ damage. We investigated retinal capillary density in patients with early disease. METHODS: This cross-sectional study compares retinal capillary rarefaction determined by intercapillary distance (ICD) and capillary area (CapA), measured non-invasively and in vivo by scanning laser Doppler flowmetry, in 73 patients with type 2 diabetes, 55 healthy controls and 134 individuals with hypertension stage 1 or 2. RESULTS: In diabetic patients, ICD was greater (23.2±5.5 vs 20.2±4.2, p = 0.013) and CapA smaller (1592±595 vs 1821±652, p = 0.019) than in healthy controls after adjustment for differences in cardiovascular risk factors between the groups. Compared to hypertensive patients, diabetic individuals showed no difference in ICD (23.1±5.8, p = 0.781) and CapA (1556±649, p = 0.768). CONCLUSION: In the early stage of diabetes type 2, patients showed capillary rarefaction compared to healthy individuals.
format Online
Article
Text
id pubmed-5147800
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51478002016-12-28 Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus Jumar, Agnes Harazny, Joanna M. Ott, Christian Friedrich, Stefanie Kistner, Iris Striepe, Kristina Schmieder, Roland E. PLoS One Research Article PURPOSE: In diabetes mellitus type 2, capillary rarefaction plays a pivotal role in the pathogenesis of end-organ damage. We investigated retinal capillary density in patients with early disease. METHODS: This cross-sectional study compares retinal capillary rarefaction determined by intercapillary distance (ICD) and capillary area (CapA), measured non-invasively and in vivo by scanning laser Doppler flowmetry, in 73 patients with type 2 diabetes, 55 healthy controls and 134 individuals with hypertension stage 1 or 2. RESULTS: In diabetic patients, ICD was greater (23.2±5.5 vs 20.2±4.2, p = 0.013) and CapA smaller (1592±595 vs 1821±652, p = 0.019) than in healthy controls after adjustment for differences in cardiovascular risk factors between the groups. Compared to hypertensive patients, diabetic individuals showed no difference in ICD (23.1±5.8, p = 0.781) and CapA (1556±649, p = 0.768). CONCLUSION: In the early stage of diabetes type 2, patients showed capillary rarefaction compared to healthy individuals. Public Library of Science 2016-12-09 /pmc/articles/PMC5147800/ /pubmed/27935938 http://dx.doi.org/10.1371/journal.pone.0162608 Text en © 2016 Jumar et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Jumar, Agnes
Harazny, Joanna M.
Ott, Christian
Friedrich, Stefanie
Kistner, Iris
Striepe, Kristina
Schmieder, Roland E.
Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus
title Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus
title_full Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus
title_fullStr Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus
title_full_unstemmed Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus
title_short Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus
title_sort retinal capillary rarefaction in patients with type 2 diabetes mellitus
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147800/
https://www.ncbi.nlm.nih.gov/pubmed/27935938
http://dx.doi.org/10.1371/journal.pone.0162608
work_keys_str_mv AT jumaragnes retinalcapillaryrarefactioninpatientswithtype2diabetesmellitus
AT haraznyjoannam retinalcapillaryrarefactioninpatientswithtype2diabetesmellitus
AT ottchristian retinalcapillaryrarefactioninpatientswithtype2diabetesmellitus
AT friedrichstefanie retinalcapillaryrarefactioninpatientswithtype2diabetesmellitus
AT kistneriris retinalcapillaryrarefactioninpatientswithtype2diabetesmellitus
AT striepekristina retinalcapillaryrarefactioninpatientswithtype2diabetesmellitus
AT schmiederrolande retinalcapillaryrarefactioninpatientswithtype2diabetesmellitus